Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal

Home page

Task 1c: Contribution of strain variability to the epidemiological patterns of infection: application to Cb in cattle

We focus on defining host health statuses with respect to pathogen characteristics.

Relating the pathogen genetic variability with the virulence variability enables the host susceptibility and infectiousness to be defined with respect to the variants of the pathogen that can be observed (simultaneously or not) in a herd. Previous work carried out by partner 1 reported a large variability in shedding routes (milk, vaginal mucus, faeces) and patterns over time (intermittent, sporadic, persistent) (Guatteo et al., 2006; 2007). It also was shown, using an original modelling-based Bayesian approach, that some herds are characterised by a very low infection risk while others have a mild infection risk and a non-negligible intermittent shedding probability (Courcoul et al., 2010). Moreover, different clinical patterns at both the animal and herd levels were observed, possibly in relation to variability in the involved strains and their associated virulence. Therefore, we will investigate the contribution of strain variability to the diversity of the shedding patterns (in terms of intensity of shedding and shedding routes as described in T1b) observed for Cb infections in cattle herds. Animals located in herds involved in an intervention study currently under progress and designed to assess the effectiveness of control strategies will be selected on the basis of their observed clinical and infection patterns. The Cb isolates from these animals will be cultivated and typed and their virulence level assessed using both in vitro and in vivo (on mice) models. Associations between the reported Cb virulence levels and the shedding patterns observed in animals according to the identified strains then will be investigated.

Depending on the results, “strain-dependent” within-herd models will be implemented from an existing simulation model representing Cb spread within an infected dairy cattle herd (Courcoul et al., 2010). We will account for the observed related variability in shedding patterns. The developed models will differ with respect to the significance of the health states considered and values of transition parameters between these states.

If several strains are observed simultaneously in a herd, a methodological issue will emerge. The formulation of the mathematical model can be complicated by the increase in the number of variants co-circulating, especially if interactions occur between variants (e.g. cross-immunity). It then will be necessary to formalise, based on published generic formulations of such multi-strains systems (Andreasen et al., 1997), a within-herd model of Cb spread considering co-circulating variants.